Nakajima Kenichirou, Hashimoto Etsuko, Kaneda Hiroyuki, Tokushige Katsutoshi, Shiratori Keiko, Hizuka Naomi, Takano Kazue
Department of Internal Medicine and Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
J Gastroenterol. 2005 Mar;40(3):312-5. doi: 10.1007/s00535-004-1541-4.
We experienced two cases of pediatric nonalcoholic steatohepatitis (NASH) associated with hypopituitarism. The first patient was diagnosed with a craniopharyngioma at 5 years of age. After an operation to treat the condition, the patient gradually became obese, and an elevation of transaminases was observed. At 16 years of age, the patient was diagnosed as having NASH with liver cirrhosis. He was started on hormone replacement therapy; however, his insulin resistance and liver fibrosis, as evaluated by hyaluronic acid and platelet count, progressed. In addition, his hyperleptinemia continued. The second patient was diagnosed, at 10 years of age, as having pituitary dysfunction due to fetal asphyxia, and he was started on hormone replacement therapy. This patient was noted to have been obese throughout his life. He was diagnosed as having NASH with advanced fibrosis at 18 years of age. It is important for both hepatologists and endocrinologists to be aware of the association between pituitary dysfunction and NASH.
我们遇到了两例与垂体功能减退相关的儿童非酒精性脂肪性肝炎(NASH)。首例患者5岁时被诊断为颅咽管瘤。在接受治疗该疾病的手术后,患者逐渐肥胖,并观察到转氨酶升高。16岁时,该患者被诊断为患有NASH伴肝硬化。他开始接受激素替代疗法;然而,通过透明质酸和血小板计数评估,他的胰岛素抵抗和肝纤维化仍在进展。此外,他的高瘦素血症持续存在。第二例患者10岁时被诊断为因胎儿窒息导致垂体功能障碍,并开始接受激素替代疗法。该患者一生都肥胖。18岁时,他被诊断为患有NASH伴晚期纤维化。肝病学家和内分泌学家都应意识到垂体功能障碍与NASH之间的关联,这一点很重要。